GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.540 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

May 13, 2026

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...

Via StockStory

Topics Economy

The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call

May 13, 2026

GoodRx saw a positive market reaction to its first-quarter results, with management attributing performance to robust growth in its Pharma Direct segment and...

Via StockStory

Topics Earnings

GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue ↗

May 10, 2026

Quarterly filings reveal markedly different revenue trajectories and margin profiles for these two healthcare platforms. What do their latest numbers indicate?

Via The Motley Fool

GoodRx Holdings Inc (NASDAQ:GDRX) Stock Falls on Cautious 2026 Revenue Outlook ↗

February 25, 2026

Via Chartmill

GoodRx (GDRX) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

GoodRx (GDRX) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

1 Mooning Stock on Our Buy List and 2 We Question

May 08, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

GoodRx (GDRX) Stock Trades Up, Here Is Why

May 07, 2026

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 7% in the afternoon session after the company reported first-quarter 2026 financ...

Via StockStory

Topics Artificial Intelligence

GoodRx (NASDAQ:GDRX) Beats Q1 CY2026 Sales Expectations

May 06, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, but sales fell by 4.4% year on year to $194 m...

Via StockStory

GoodRx Reports First Quarter 2026 Results

May 06, 2026

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

May 04, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday afternoon. Here’s what to look for. GoodRx beat analysts’ rev...

Via StockStory

Topics Artificial Intelligence

Why GoodRx (GDRX) Stock Is Trading Up Today

May 01, 2026

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 9.5% in the afternoon session after it announced it would provide access to Novo...

Via StockStory

Topics Artificial Intelligence

GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

May 01, 2026

From GoodRx

Via Business Wire

Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

April 21, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno...

Via StockStory

1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

April 20, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

April 17, 2026

From GoodRx Holdings, Inc.

Via Business Wire

3 Reasons GDRX is Risky and 1 Stock to Buy Instead

April 16, 2026

GoodRx’s stock price has taken a beating over the past six months, shedding 40.7% of its value and falling to $2.31 per share. This was partly due to its sof...

Via StockStory

Topics Supply Chain

Why GoodRx (GDRX) Stock Is Up Today

April 15, 2026

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.6% in the afternoon session after the company announced it now offers access t...

Via StockStory

GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

April 15, 2026

From GoodRx

Via Business Wire

GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

April 09, 2026

From GoodRx

Via Business Wire

1 Healthcare Stock on Our Watchlist and 2 We Avoid

April 09, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...

Via StockStory

1 Value Stock with Exciting Potential and 2 Facing Challenges

March 24, 2026

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Via StockStory

2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm

March 13, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

March 11, 2026

From GoodRx

Via Business Wire

Option Care Health, CooperCompanies, Neogen, GoodRx, and Fortrea Shares Are Falling, What You Need To Know

March 06, 2026

Via StockStory

Topics Economy

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

March 06, 2026

From GoodRx

Via Business Wire

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

February 27, 2026

A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key...

Via StockStory

Topics Economy Government Stocks

GoodRx (GDRX) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

GoodRx (GDRX) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Bankruptcy Earnings

GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8%

February 25, 2026

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.9% year on year to $194.8 million. On the other hand, the...

Via StockStory

Top movers in Wednesday's after hours session ↗

February 25, 2026

Via Chartmill

GoodRx Reports Fourth Quarter and Full Year 2025 Results

February 25, 2026

From GoodRx Holdings, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.